Kalaris Therapeutics, Inc. — Cash Flow Charts
3 quarters of history · ending 2019-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
—
Free Cash Flow
$-121K
Investing Cash Flow
$35M
Financing Cash Flow
$0
Capex
$121K
Stock-Based Comp
$622K
D&A
—
SBC Allocated Expense
$622K